Mglide

Mglide has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 20, 2026: “mHealth Intervention to Improve Hypertension Care in High-Risk Patients”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on mglide

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“The adjusted mean difference between groups for the primary outcome of 6-month SBP favored mGlide: -5.8 mm Hg (95% CI, -8.6 to -3.0)”
mHealth Intervention to Improve Hypertension Care in High-Risk PatientsHypertension (Dallas, Tex. : 1979)2026doi:10.1161/hypertensionaha.125.26148

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Center for Advancing Translational Sciences and 3 more
  • 2 of 2 findings with company ties
  • Human trial1

Studies in people

1 study gave mglide to people and measured what changed.

What changedDesignPeopleSource

down: Decreases systolic blood pressure-5.8 mm Hg (95% CI, -8.6 to -3.0)

down: Decreases ambulatory systolic blood pressure4.8 mm Hg lower (P=0.014)

Randomized trial6 months395 peopleBoth66.9 yearsOlder adults; uncontrolled hypertensionHypertension (Dallas, Tex. : 1979), Feb 20, 2026

What did studies of mglide find?

2

Studies of mglide measured 2 outcomes: ambulatory systolic blood pressure and systolic blood pressure.

Ambulatory systolic blood pressure

downin humans1

1 study
  1. Mglide decreases ambulatory systolic blood pressure in humans (uncontrolled hypertension) (4.8 mm Hg lower (P=0.014)).

    “The mGlide arm also had a 4.8 mm Hg (P=0.014) lower 24-hour average ambulatory SBP.”

    Human trialuncontrolled hypertension6 monthsn = 395

    mHealth Intervention to Improve Hypertension Care in High-Risk Patients

    Hypertension (Dallas, Tex. : 1979)

More on Ambulatory systolic blood pressure

Systolic blood pressure

downin humans1

1 study
  1. Mglide decreases systolic blood pressure in humans (uncontrolled hypertension) (-5.8 mm Hg (95% CI, -8.6 to -3.0)).

    “The adjusted mean difference between groups for the primary outcome of 6-month SBP favored mGlide: -5.8 mm Hg (95% CI, -8.6 to -3.0)”

    Human trialuncontrolled hypertension6 monthsn = 395

    mHealth Intervention to Improve Hypertension Care in High-Risk Patients

    Hypertension (Dallas, Tex. : 1979)

More on Systolic blood pressure

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months